Cargando…
Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878844/ https://www.ncbi.nlm.nih.gov/pubmed/33604503 http://dx.doi.org/10.1093/rap/rkaa082 |
| _version_ | 1783650406330531840 |
|---|---|
| author | Saur, Sebastian-Jonas Horger, Marius Henes, Jörg |
| author_facet | Saur, Sebastian-Jonas Horger, Marius Henes, Jörg |
| author_sort | Saur, Sebastian-Jonas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7878844 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78788442021-02-17 Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis Saur, Sebastian-Jonas Horger, Marius Henes, Jörg Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2021-01-20 /pmc/articles/PMC7878844/ /pubmed/33604503 http://dx.doi.org/10.1093/rap/rkaa082 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor (Case report) Saur, Sebastian-Jonas Horger, Marius Henes, Jörg Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title | Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title_full | Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title_fullStr | Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title_full_unstemmed | Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title_short | Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis |
| title_sort | successful treatment with the il12/il23 antagonist ustekinumab in a patient with refractory takayasu arteritis |
| topic | Letter to the Editor (Case report) |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878844/ https://www.ncbi.nlm.nih.gov/pubmed/33604503 http://dx.doi.org/10.1093/rap/rkaa082 |
| work_keys_str_mv | AT saursebastianjonas successfultreatmentwiththeil12il23antagonistustekinumabinapatientwithrefractorytakayasuarteritis AT horgermarius successfultreatmentwiththeil12il23antagonistustekinumabinapatientwithrefractorytakayasuarteritis AT henesjorg successfultreatmentwiththeil12il23antagonistustekinumabinapatientwithrefractorytakayasuarteritis |